Business

Meishe Network Technology helps Bilibili to launch a new version of cloud clipping and upgrade the user experience.

Beijing Meishe Network Technology Co., Ltd.

​Bilibili, a popular Chinese danmaku video website, recently told the old web video editor to go offline. The new version of cloud clipping has been put online. It can be operated directly in a web browser without downloading. Compared to the old Web video editor, the new cloud Clipping is a complete upgrade to the user experience.

全球英文顶媒【H1】全球【英语500+】

【单词数量1500个以内+含1张图+免费翻译+官方首发】。媒体:彭博社、朝日新闻、雅虎新闻、雅虎财经、Fresheye、财经(德国)、Asiaone、纳斯达克、Marketwatch、Streetinsider、晨星网等代表性媒体【随机顶媒10+】

美联社【H】美联社美国【英语300+】

美联社【H】 美联社美国【英语300+】报表反馈1-2个工作日 【单词数量1500个+含2张图+免费翻译】。媒体:雅虎新闻、雅虎财经、美联社99%图片不一定能出【随机顶媒5+】

Closure of China’s Consulate in Houston, a strategic move or a provocative step?

Karen Douglas

July 27, 2020 US State Department’s order to abruptly shut the Chinese consulate in Houston has stirred up and escalated tensions between US and China in recent days. Many scholars, political analysts, commentators or insiders in diplomatic community are wondering whether this move is a sustainable strategy to contain China or a part of a series of provocative and reckless steps rolled out in rec

The three-in-one Tinanik sunscreen innovates sun-proof, whitening and anti-aging

IRIS BUSINESS LTD

As everyone knows, sunscreen has a very important position in the skin-care industry. It can not only prevent sunburn, but also play an important role in reducing the incidence rate of skin cancer. With the improvement of people’ s requirements for sunscreen, single sunscreen efficacy can not meet the needs of consumers. Nowadays, women proposed new requirements, like refuse sunburn, whitening and

Bayer and OrigiMed reached a partnership on CDx-IVD development

OrigiMed

Bayer and OrigiMed (Shanghai) Co., Ltd. (referred to as "OrigiMed") today announced a strategic collaboration for the development and commercialization of NGS-based companion diagnostics – in vitro diagnostic (CDx-IVD) in China for detection of NTRK gene fusions. This collaboration will focus on developing a CDx-IVD for larotrectinib (Vitrakvi®) for the Chinese market, the first TRK inhibitor appr

Home Previous 387 388 389 390 391 392 393 Next Tail

10 Items Per Page (Page 390 / 397) Total 3961 Items

©copyright 2009-2020 Bit Bit Daily      Contact Us   SiteMap